Abstract
Purpose
We present a case series of patients with multiple sclerosis (MS) and neurogenic lower urinary tract dysfunction treated by sacral neuromodulation (SNM).
Methods
We reviewed charts of 25 patients who were treated for refractory lower urinary tract symptoms; during the SNM testing phase, patient management included evaluation of number of daily voiding, number of episodes of incontinence, residual urine and quality of life score. Patients who experienced greater than 50% improvement in symptoms of frequency and incontinence episodes and/or a greater than 50% decrease in the number of catheterizations and a greater than 50% increase in voided volumes were offered placement of the permanent InterStimTM .
Results
Fifteen patients were implanted with InterStimTM; mean duration of MS was 13.66 years; mean follow-up of patients was 49.4 months. Nine patients were on clean intermittent catheterization, and in all of them, a significant decrease in residual volume with increase in voided volume and number of voiding per day; in 6 patients, the main problem was incontinence, and in them incontinence, episodes decreased and voided volume increased. Sixty-six per cent of patients have a functioning device after a mean follow-up of 61.2 months.
Conclusions
SNM is a good option in the treatment of voiding dysfunction in patients with MS in a medium to long-term follow-up. Urinary retention due to detrusor underactivity is not a good indication for SNM; it should be offered to MS patients with refractory urgency urinary incontinence and MS patients with urinary retention due to detrusor-sphincter dyssynergia (DSD).
Similar content being viewed by others
References
Marinkovic SP, Gillen LM (2010) Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J Pelvic Floor Dysfunct 21(2):223–228
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517
Fowler CJ, van Kerrebroeck PE, Nordenbo A, van Poppel H (1992) Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 55:986–989
Ruud Bosh JLH (1998) Neuromodulation: urodynamic effects of sacral (S3)spinal nerve stimulation in patients with detrusor instability or detrusor hyperreflexia. Behav Brain Res 92:141–150
Ciancio SJ, Mutchnik SE, Rivera VM, Boone TB (2001) Urodynamic pattern changes in multiple sclerosis. Urology 57:239–245
Minardi D, Muzzonigro G (2005) Lower urinary tract and bowel disorders and multiple sclerosis: role of sacral neuromodulation. A preliminary report. Neuromodulation 8:176–181
Calabresi PA (2004) Diagnosis and management of multiple sclerosis. Am Fam Physician 70:1935–1944
Littwiller SE, Frohman E, Zimmern P (1999) Multiple sclerosis and the urologist. J Urol 161:743–757
Hennessey A, Robertson NP, Swingler R, Compston DA (1999) Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol 246:1027–1032
Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D (2007) Disparities in the management of multiple sclerosis –related bladder symptoms. Neurology 68:1971–1978
Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Vespasiani G, Castellano V (1998) Urological dysfunction and upper tract involvement in multiple sclerosis patients. Neurourol Urodyn 17:89–98
DasGupta R, Fowler CJ (1995) Bladder, bowel and sexual dysfunction in multiple sclerosis. Management strategies. Drugs 63:153–166
Burks FN, Diokno AC, Laijness MJ, Ibrahim IA, Peters KM (2008) Sacral neuromodulation reprogramming: is it an office burden. Int Urogynecol J Pelvic Floor Dysfunct 19:1137–1140
Roth TM (2007) Sacral neuromodulation and lower urinary tract dysfunction in cerebral plasy. Int Urogynecol J Pelvic Floor Dysfunct 18:567–569
De Ridder D, Ost D, van der Aa F, Stagnaro M, Beneton C, Gross-Paju K, Eelen P, Limbourg H, Harper M, Segal JC, Fowler CJ, Nordenbo A (2005) Conservative bladder management in advanced multiple sclerosis. Multiple Scler 11:694–699
Wagner TH, Patrick DL, Bevendam TG, Bueshing DP (1996) Quality of life of persons with urinary incontinence: development of a new measure. Urology 47:67–70
Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P, International Continence Society (2002) Good urodynamic practices: uroflowmetry, filling cystometry and pressure-flow studies. Neurourol Urodyn 21:261–274
Minardi D, Parri G, d’Anzeo G, Fabiani A, El Asmar Z, Muzzonigro G (2008) Perineal ultrasound evaluation of dysfunctional voiding in women with recurrent urinary tract infections. J Urol 179:947–951
Spinelli M, Bertapelle P, Cappellano F, Zanollo A, Carone R, Catanzaro F, Giardiello G, De Seta F (on behalf of the GINS group) (2001) Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol 166:541–545
Spinelli M, Sievert KD (2008) Latest technology and surgical developments in using InterStimTM therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol 54:1287–1296
Wallace PA, Lane FL, Noblett KL (2007) Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Ostr Gynecol 197(1):96.e1–96.e5
Chartier-Kastler EJ, Ruud Bosch JLH, Perrigot M, Chancellor MB, Richard F, Denys P (2000) Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol 164:1476–1480
Bemelmans BL, Mundy AR, Craggs MD (1999) Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol 36:81–91
Bosch JLHR, Groen J (2000) Sacral neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of prospective longitudinal study. J Urol 163:1849–1854
Acknowledgments
We thank Dr. Limido Lucia (Medtronic—Italia S.p.A.) for technical advice.
Conflict of interest
The authors certify that there is no actual or potential conflict of interest in relation to this article
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Minardi, D., Muzzonigro, G. Sacral neuromodulation in patients with multiple sclerosis. World J Urol 30, 123–128 (2012). https://doi.org/10.1007/s00345-011-0669-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-011-0669-0